A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.
A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.
Recruiting · NCT07460986 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma. | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-08-31 | NCT07460986 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Faron Pharmaceuticals Ltd | 4 |
| MedSIR | 19 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínico San Carlos | Madrid | Spain | 30 |
| Hospital de Cruces | Barakaldo | Spain | 7 |
| Hospital Universitari Vall D'Hebron (VHIO) | Barcelona | Spain | 1 |
| Hospital Universitario de Canarias | San Cristóbal de La Laguna | Spain | 9 |
| Hospital Universitario Doce de Octubre | Madrid | Spain | 4 |
| Hospital Universitario Gregorio Marañón | Madrid | Spain | 7 |
| Hospital Universitario La Paz | Madrid | Spain | 75 |
| Hospital Universitario Miguel Servet | Zaragoza | Spain | 27 |
| Hospital Universitario Virgen de la Victoria | Málaga | Spain | 24 |
| Hospital Universitario Virgen del Rocío | Seville | Spain | 37 |
| Institut Català d' Oncologia Badalona (ICO) | Badalona | Spain | 3 |